Defining long-term maintenance conditions of human embryonic stem cells with arrayed cellular microenvironment technology.

The optimization of defined growth conditions is necessary for the development of clinical application of human embryonic stem cells (hESCs). Current research has focused on developing defined media formulations for long-term culture of hESCs with little attention on the establishment of defined substrates for hESC proliferation and self-renewal. Presently available technologies are insufficient to address the full complement of factors that may regulate hESC proliferation and maintenance of pluripotency. Here, we report the application of a multifactorial array technology to identify fully defined and optimized culture conditions for the proliferation of hESCs. Through the systematic screening of extracellular matrix proteins (ECMPs) and other signaling molecules, we developed and characterized a completely defined culture system for the long-term self-renewal of three independent hESC lines. In the future, the novel array platform and analysis procedure presented here will be applied toward the directed differentiation of hESCs and maintenance of other stem and progenitor cell populations.

[1]  Shu Chien,et al.  Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. , 2010, Biomaterials.

[2]  Jennifer M. Singelyn,et al.  Injectable Materials for the Treatment of Myocardial Infarction and Heart Failure: The Promise of Decellularized Matrices , 2010, Journal of cardiovascular translational research.

[3]  J. Lahann,et al.  Synthetic polymer coatings for long-term growth of human embryonic stem cells , 2010, Nature Biotechnology.

[4]  J. Shiloach,et al.  Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen. , 2010, Stem cells and development.

[5]  Sean P Palecek,et al.  Development of Scalable Culture Systems for Human Embryonic Stem Cells. , 2010, Biochemical engineering journal.

[6]  L. V. Van Laake,et al.  Recombinant Vitronectin Is a Functionally Defined Substrate That Supports Human Embryonic Stem Cell Self‐Renewal via αVβ5 Integrin , 2008, Stem cells.

[7]  N. Socci,et al.  High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. , 2008, Cell stem cell.

[8]  Shu Chien,et al.  Combinatorial signaling microenvironments for studying stem cell fate. , 2008, Stem cells and development.

[9]  Sean P. Palecek,et al.  Retinoic Acid and Bone Morphogenetic Protein Signaling Synergize to Efficiently Direct Epithelial Differentiation of Human Embryonic Stem Cells , 2008, Stem cells.

[10]  Angelique M. Nelson,et al.  Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB 2 receptor signaling , 2007 .

[11]  G. Churchill,et al.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative , 2007, Nature Biotechnology.

[12]  H. Kleinman,et al.  Cell‐Cell and Cell‐Extracellular Matrix Interactions Regulate Embryonic Stem Cell Differentiation , 2007, Stem cells.

[13]  T. Okamoto,et al.  Immunohistochemical expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) as an angiogenic factor in head and neck tumorigenesis. , 2007, Oncology reports.

[14]  C Anthony Blau,et al.  A Comparison of NIH‐Approved Human ESC Lines , 2006, Stem cells.

[15]  Heli Skottman,et al.  Culture conditions for human embryonic stem cells. , 2006, Reproduction.

[16]  Yoav Soen,et al.  Exploring the regulation of human neural precursor cell differentiation using arrays of signaling microenvironments , 2006, Molecular systems biology.

[17]  Sheng Ding,et al.  Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Thomson,et al.  Derivation of human embryonic stem cells in defined conditions , 2006, Nature Biotechnology.

[19]  Z. Szallasi,et al.  Reliability and reproducibility issues in DNA microarray measurements. , 2006, Trends in genetics : TIG.

[20]  A. Pyle,et al.  Neurotrophins mediate human embryonic stem cell survival , 2006, Nature Biotechnology.

[21]  M. Kubista,et al.  Monitoring Differentiation of Human Embryonic Stem Cells Using Real‐Time PCR , 2005, Stem cells.

[22]  A. Pébay,et al.  Essential Roles of Sphingosine‐1‐Phosphate and Platelet‐Derived Growth Factor in the Maintenance of Human Embryonic Stem Cells , 2005, Stem cells.

[23]  E. Brunette,et al.  Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. , 2005, Biotechnology and bioengineering.

[24]  M. Stojkovic,et al.  Human‐Serum Matrix Supports Undifferentiated Growth of Human Embryonic Stem Cells , 2005, Stem cells.

[25]  S. Fisher,et al.  Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. , 2005, Fertility and sterility.

[26]  Kathleen F. Kerr,et al.  Standardizing global gene expression analysis between laboratories and across platforms , 2005, Nature Methods.

[27]  Ana D. Lopez,et al.  Activin A Maintains Pluripotency of Human Embryonic Stem Cells in the Absence of Feeder Layers , 2005, Stem cells.

[28]  Ariel J. Levine,et al.  TGFβ/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells , 2005 .

[29]  J. Lebkowski,et al.  Basic Fibroblast Growth Factor Supports Undifferentiated Human Embryonic Stem Cell Growth Without Conditioned Medium , 2005, Stem cells.

[30]  J. Thomson,et al.  Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells , 2005, Nature Methods.

[31]  S. Bhatia,et al.  An extracellular matrix microarray for probing cellular differentiation , 2005, Nature Methods.

[32]  N. Gorfinkiel,et al.  The Drosophila ortholog of the human Wnt inhibitor factor Shifted controls the diffusion of lipid-modified Hedgehog. , 2005, Developmental cell.

[33]  Ariel J. Levine,et al.  TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. , 2005, Development.

[34]  Daniel G. Anderson,et al.  Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells , 2004, Nature Biotechnology.

[35]  A. Lindahl,et al.  Derivation, Characterization, and Differentiation of Human Embryonic Stem Cells , 2004, Stem cells.

[36]  J. Itskovitz‐Eldor,et al.  Feeder Layer- and Serum-Free Culture of Human Embryonic Stem Cells1 , 2004, Biology of reproduction.

[37]  P. Greengard,et al.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.

[38]  M. Pera,et al.  Characterization and culture of human embryonic stem cells. , 2003, Trends in cardiovascular medicine.

[39]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.

[40]  Chunhui Xu,et al.  Feeder-free growth of undifferentiated human embryonic stem cells , 2001, Nature Biotechnology.

[41]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[42]  J. Fléchon,et al.  Immunocytochemical characterisation of rabbit and mouse embryonic fibroblasts. , 1998, Reproduction, nutrition, development.

[43]  A. Wellstein,et al.  Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. , 1994, The Journal of biological chemistry.

[44]  M. Wicha,et al.  Extracellular matrix promotes the growth and differentiation of murine hematopoietic cells in vitro. , 1985, The Journal of clinical investigation.

[45]  Sidney Addelman,et al.  trans-Dimethanolbis(1,1,1-trifluoro-5,5-dimethylhexane-2,4-dionato)zinc(II) , 2008, Acta crystallographica. Section E, Structure reports online.